"The IPSS — How Urologists Rate BPH Symptoms"
If you've been to a urologist with urinary symptoms in the last 30 years, you've taken the IPSS — the International Prostate Symptom Score (also called the AUA-SI, after the American Urological Association). It's a 7-question survey that has become the standard way to measure how much benign prostatic hyperplasia (BPH) is interfering with daily life. Plus a separate 8th question on quality of life.
Walking in with the score already calculated saves the visit a step, and it gives you a number to track over time as treatment (or watchful waiting) plays out.
The seven symptom questions
All ask "over the past month, how often have you..." with two slightly different scales depending on the question.
For the first six (sensation of incomplete emptying, frequency, intermittency, urgency, weak stream, straining), the scale is:
- 0 — Not at all
- 1 — Less than 1 time in 5
- 2 — Less than half the time
- 3 — About half the time
- 4 — More than half the time
- 5 — Almost always
The seventh question is about nocturia — how many times you typically get up to urinate from going to bed to getting up. It uses a count scale instead:
- 0 — Never
- 1 — 1 time
- 2 — 2 times
- 3 — 3 times
- 4 — 4 times
- 5 — 5 or more times
Each question scores 0–5, total range 0–35.
The score categories
These are the thresholds that drive treatment-decision conversations:
- 0–7: Mild symptoms — watchful waiting is reasonable. Lifestyle adjustments (limiting fluid before bed, avoiding bladder irritants like caffeine and alcohol, treating constipation if present) often help. Re-screen in 6–12 months.
- 8–19: Moderate symptoms — the threshold where most clinical guidelines recommend talking to your provider about evaluation and treatment options. Treatments range from alpha-blockers (tamsulosin, alfuzosin), 5-alpha-reductase inhibitors (finasteride, dutasteride), combination therapy, minimally-invasive procedures (Rezum, UroLift), to TURP for severe cases.
- 20–35: Severe symptoms — active treatment is typically warranted at this level. Symptoms this disruptive don't usually resolve on their own.
The quality-of-life question
The 8th question is scored 0–6 and reported separately from the total:
> "If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that?"
- 0 — Delighted
- 1 — Pleased
- 2 — Mostly satisfied
- 3 — Mixed
- 4 — Mostly dissatisfied
- 5 — Unhappy
- 6 — Terrible
This matters because a moderate IPSS total (say, 12) might be very tolerable for one person and intolerable for another. The QoL score captures the personal impact in a way the symptom count alone doesn't. Two people with identical IPSS totals can have very different treatment urgency.
What the questions are actually getting at
Each item points at a slightly different aspect of bladder outlet obstruction or detrusor (bladder muscle) function:
- Incomplete emptying — bladder isn't fully draining; can predispose to UTIs and stones
- Frequency — small functional bladder capacity, often from chronic obstruction
- Intermittency — start-stop urination; suggests obstruction interrupting flow
- Urgency — overactive bladder component, often coexisting with BPH
- Weak stream — direct measure of obstruction at the bladder neck
- Straining — significant obstruction requiring abdominal muscle assist
- Nocturia — often the most life-disrupting symptom; multiple causes including obstruction, polyuria, sleep apnea, fluid timing
The fact that the IPSS captures all seven matters because BPH treatments have different effects on different symptoms. Alpha-blockers help flow and emptying quickly. 5-ARIs shrink the prostate over months and reduce all symptoms gradually. Anticholinergics help urgency and frequency but can worsen retention. The symptom profile guides the treatment.
What the IPSS doesn't tell you
The IPSS measures symptoms, not the underlying cause. The same symptoms can come from:
- BPH (most common cause in older men)
- Bladder cancer (especially with hematuria)
- Prostate cancer (uncommonly causes urinary symptoms — usually the cancer is advanced if so)
- Urinary tract infection
- Bladder stones
- Neurogenic bladder (multiple sclerosis, diabetes, spinal cord injury)
- Medication effects (anticholinergics, decongestants)
Which is why a high IPSS leads to evaluation — urinalysis, sometimes PSA, sometimes ultrasound to check post-void residual, sometimes urodynamic testing — not directly to BPH treatment.
Tracking the IPSS over time
The IPSS is designed for repeated use. Many BPH treatments take weeks to months to reach full effect, and tracking the score across that period is how clinicians (and patients) decide whether something is working. A score that drops from 18 to 9 on alpha-blocker therapy is dramatic improvement; a score that stays at 17 suggests the treatment isn't doing it.
Skip the clipboard
The Prostate Symptom Score tool gives you the IPSS with auto-scoring, the QoL question reported separately (because it isn't summed into the total), and clinical-handoff phrasing for the visit. Optional history saving (off by default) lets you compare scores across visits to see treatment effect. Same on-device privacy as the rest of /health.
The short version
7 questions, scored 0–35. Categories: mild (0–7), moderate (8–19), severe (20+). Plus a separate QoL score that captures the personal impact a number alone misses. Bringing the score to a urology visit saves 5 minutes of the appointment, and tracking it across treatment is how you and your provider know whether something's working.